The Drug-Drug Interactions Ontology

Last uploaded: February 11, 2016
Preferred Name

silodosin

Synonyms

C25H32F3N3O4

1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide

ID

http://purl.obolibrary.org/obo/dinto_DB06207

ATCCode

G04CA04

blocks

http://purl.obolibrary.org/obo/dinto_4020

http://purl.obolibrary.org/obo/dinto_3475

http://purl.obolibrary.org/obo/dinto_0234

CASRN

160970-54-7

DBBrand

rapilif

silodyx

rapaflo

urief

DBSynonym

kad 3213

kmd 3213

Definition

Silodosin is an ?1-adrenoceptor antagonist that is selective for the prostate. Silodosin is for symptomatic treatment of benign prostatic hyperplasia. FDA approved Oct 9, 2008.

has effect

http://purl.obolibrary.org/obo/OAE_0000388

http://purl.obolibrary.org/obo/OAE_0000377

http://purl.obolibrary.org/obo/OAE_0000335

http://purl.obolibrary.org/obo/OAE_0000567

http://purl.obolibrary.org/obo/OAE_0000382

http://purl.obolibrary.org/obo/OAE_0000551

http://purl.obolibrary.org/obo/OAE_0000400

http://purl.obolibrary.org/obo/OAE_0002206

http://purl.obolibrary.org/obo/OAE_0000468

http://purl.obolibrary.org/obo/OAE_0000487

http://purl.obolibrary.org/obo/OAE_0000336

http://purl.obolibrary.org/obo/OAE_0000362

http://purl.obolibrary.org/obo/OAE_0000374

http://purl.obolibrary.org/obo/OAE_0000402

has pharmacological target

http://purl.obolibrary.org/obo/dinto_0234

InChI

InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1

InChIKey

InChIKey=PNCPYILNMDWPEY-QGZVFWFLSA-N

is metabolised by

http://purl.obolibrary.org/obo/dinto_1890

http://purl.obolibrary.org/obo/dinto_0901

is transported by

http://purl.obolibrary.org/obo/dinto_1988

http://purl.obolibrary.org/obo/dinto_1440

label

silodosin

may interact with

http://purl.obolibrary.org/obo/CHEBI_9948

http://purl.obolibrary.org/obo/CHEBI_39867

http://purl.obolibrary.org/obo/dinto_DB00224

http://purl.obolibrary.org/obo/dinto_DB00196

http://purl.obolibrary.org/obo/CHEBI_101278

http://purl.obolibrary.org/obo/CHEBI_61049

http://purl.obolibrary.org/obo/CHEBI_17698

http://purl.obolibrary.org/obo/dinto_DB01167

http://purl.obolibrary.org/obo/CHEBI_681850

http://purl.obolibrary.org/obo/CHEBI_9445

http://purl.obolibrary.org/obo/dinto_DB00582

http://purl.obolibrary.org/obo/CHEBI_9398

http://purl.obolibrary.org/obo/dinto_DB00199

http://purl.obolibrary.org/obo/dinto_DB00503

http://purl.obolibrary.org/obo/dinto_DB01026

http://purl.obolibrary.org/obo/CHEBI_8426

http://purl.obolibrary.org/obo/CHEBI_46295

prefixIRI

obo2:dinto_DB06207

prefLabel

silodosin

SMILES

C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F

Synonym

C25H32F3N3O4

1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide

xref

Drugs.com:http://www.drugs.com/cdi/silodosin.html

PharmGKB:PA165291889

ChemSpider:4471557

Wikipedia:http://en.wikipedia.org/wiki/Silodosin

RxList:http://www.rxlist.com/rapaflo-capsules-drug.htm

PubChem Compound:5312125

National Drug Code Directory:54868-6173-0

BindingDB:50160154

PubChem Substance:7849027

subClassOf

http://purl.obolibrary.org/obo/dinto_000055

Delete Subject Author Type Created
No notes to display